 May 7, 2021 Breda, the Netherlands argenx Euronext Nasdaq: ARGX, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Friday, May 14, 2021 at 2:30 p.m. CET 8:30 a.m. ET to discuss its first quarter 2021 financial results and provide a business update. 